A randomized, phase II study of the anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cance...

por Lin, Edward H, Lenz, Heinz-Josef, Saleh, Mansoor N, Mackenzie, Mary J, Knost, James A, Pathiraja, Kumudu, Langdon, Ronald B, Yao, Siu-Long, Lu, Brian D
Publicado 2014